News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
218 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
2 (186)
3 (175)
4 (147)
5 (166)
6 (119)
9 (121)
10 (183)
11 (172)
12 (142)
13 (112)
14 (38)
15 (1)
16 (171)
17 (154)
18 (148)
19 (149)
20 (92)
21 (2)
23 (153)
24 (148)
25 (216)
26 (204)
27 (119)
28 (2)
29 (9)
30 (193)
31 (218)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
9
10
11
12
13
14
15
16
17
18
19
20
21
23
24
25
26
27
28
29
30
31
Business
Thermo Fisher Scientific Signs Oncology Companion Diagnostic Development Agreement With Blueprint Medicines
Thermo Fisher Scientific announced today it has expanded the development of its Oncomine Dx Target Test as a CDx for BLU-667 by entering into an agreement with Blueprint Medicines.
October 31, 2017
·
3 min read
Policy
Mylan Provides Statement in Response to Announcement of Proposed Amendments to Civil Complaint
Mylan expects to have no further comment while the matter is pending.
October 31, 2017
·
1 min read
BioForest
Findings of NIH-Funded Pilot Study Suggest Home-Delivered Nutritional Meals May Lower Patient Readmission Rates and Improve Health Outcomes
A wide variety of meals were available, catering to individualized personal tastes, and as a result, more than three quarters of the participants enjoyed the meals at least 80 percent of the days.
October 31, 2017
·
3 min read
Policy
Verastem Announces Regulatory Strategy for Duvelisib New Drug Application Following Guidance From FDA
The Company expects to submit the duvelisib NDA during the first quarter of 2018.
October 31, 2017
·
8 min read
Biotech Beach
PROCEPT BioRobotics Announces Milestones in Europe: First Commercial Aquablation Cases Completed in Germany and Initiation of FRANCAIS WATER Clinical Trial
In France, PROCEPT BioRobotics received approval for and has initiated FRANCAIS WATER, a single arm, multi-center prospective clinical trial to determine the safety and efficacy of the AquaBeam System in the treatment of BPH in men 45 to 80 years of age.
October 31, 2017
·
4 min read
Bio NC
410 Medical Presents LifeFlow Simulation Data at ACEP17
The goal of the study was to compare 410 Medical’s LifeFlow Rapid Infuser to pressure bag for administering fluid boluses in simulated pre-hospital and hospital settings.
October 31, 2017
·
2 min read
FDA
Sensus Healthcare Announces Clearance to Market the SRT-100 in Mexico
Sensus Healthcare’s SRT-100 is now cleared for sale in Mexico and is approved for the treatment of non-melanoma skin cancer and keloids.
October 31, 2017
·
6 min read
Business
Rigel Announces Conference Call and Webcast to Report Third Quarter 2017 Financial Results
Rigel today announced that it will report its third quarter financial results after market close on Tuesday, November 7, 2017.
October 31, 2017
·
1 min read
Business
Bio-Techne Releases First Quarter Fiscal 2018 Results
First quarter organic revenue increased by 8% to $144.6M.
October 31, 2017
·
24 min read
Business
Bio-Techne Corp. Declares Dividend
The quarterly dividend will be payable November 24, 2017 to all common shareholders of record on November 10, 2017.
October 31, 2017
·
1 min read
Previous
14 of 22
Next